| Literature DB >> 35198643 |
Dominic K Chan1, Brittany D Alegria2, Smitha R Chadaga3, Lisa J Goren2, Traci J Mikasa4, Anna M Pearson5, Seth R Podolsky6, Regina S Won7, Jennifer L LeTourneau8.
Abstract
BACKGROUND: In the third quarter of 2021, government entities enacted vaccine requirements across multiple employment sectors, including healthcare. Experience from previous vaccination campaigns within healthcare emphasize the need to translate community modalities of vaccine outreach and education that partner with Black communities, Indigenous communities, and communities of Color stakeholders to increase vaccine confidence broadly.Entities:
Keywords: COVID-19; SARS-CoV-2; health personnel; vaccines
Year: 2022 PMID: 35198643 PMCID: PMC8860151 DOI: 10.1093/ofid/ofac012
Source DB: PubMed Journal: Open Forum Infect Dis ISSN: 2328-8957 Impact factor: 3.835
Figure 1.Distribution of interventions and number of first doses given to employees.
Employee Demographics Before Intervention
| All Employees | American Indian/Alaskan Native | Asian/Pacific Islander | Black | Hispanic | Hawaiian/Other Pacific Islander | White | Two or More Races (Not Hispanic) | Not Indicated | |
|---|---|---|---|---|---|---|---|---|---|
| Employees, N (%) | 13 942 | 87 (0.6%) | 1204 (8.6%) | 566 (4.1%) | 1175 (8.4%) | 121 (0.9%) | 10351 (74.2%) | 399 (2.9%) | 39 (0.3%) |
| Age, Years | |||||||||
| <40 | 6054 (43.4%) | 33 (37.9%) | 547 (45.4%) | 236 (41.7%) | 716 (60.9%) | 57 (47.1%) | 262 (65.7%) | 4176 (40.3%) | 27 (69.2%) |
| 40–64 | 7334 (52.6%) | 52 (60%) | 613 (50.9%) | 304 (53.7%) | 441 (37.5%) | 60 (49.6%) | 132 (33.1%) | 5720 (55.3%) | 12 (30.8%) |
| >65 | 554 (4.0%) | 2 (2.3%) | 44 (3.7%) | 26 (4.6%) | 18 (1.5%) | 4 (3.3%) | 5 (1.3%) | 455 (4.4%) | 0 |
| Gender | |||||||||
| Female | 10 715 (76.9%) | 67 (77%) | 862 (71.6%) | 406 (71.7%) | 880 (74.9%) | 86 (71.1%) | 312 (78.2%) | 8071 (78%) | 31 (79.5%) |
| Male | 3222 (23.1%) | 20 (23%) | 341 (28.3%) | 160 (28.3%) | 295 (25.1%) | 35 (29%) | 87 (21.8%) | 2277 (22%) | 7 (17.9%) |
| Not indicated | 5 (0.04%) | 0 | 1 (.08%) | 0 | 0 | 0 | 0 | 3 (.03%) | 1 (2.6%) |
| Job Class | |||||||||
| Safety/Security | 130 | 1 (0.8%) | 5 (3.8%) | 9 (6.9%) | 15 (11.5%) | 1 (0.8%) | 92 (70.8%) | 7 (5.4%) | 0 |
| Housekeeping Services | 533 | 7 (1.3%) | 73 (13.7%) | 114 (21.4%) | 109 (20.5%) | 26 (4.9%) | 189 (35.5%) | 13 (2.4%) | 2 (0.4%) |
| Patient Care, non-RN | 1314 | 16 (1.2%) | 110 (8.4%) | 85 (6.5%) | 219 (16.7%) | 17 (1.3%) | 819 (62.3%) | 45 (3.4%) | 3 (0.2%) |
| Food and Nutrition Services | 428 | 3 (0.7%) | 67 (15.7%) | 43 (10.0%) | 79 (18.5%) | 14 (3.3%) | 210 (49.1%) | 11 (2.6%) | 1 (0.2%) |
| Facilities Maintenance | 157 | 1 (0.6%) | 5 (3.2%) | 2 (1.3%) | 8 (5.1%) | 3 (1.9%) | 137 (87.3%) | 1 (0.6%) | 0 |
| Clinics | 323 | 2 (0.6%) | 16 (5.0%) | 9 (2.8%) | 38 (11.8%) | 2 (0.6%) | 246 (76.2%) | 9 (2.8%) | 1 (0.3%) |
| Health Information Management | 351 | 2 (0.6%) | 25 (7.1%) | 30 (8.5%) | 43 (12.3%) | 6 (1.7%) | 231 (65.8%) | 12 (3.4%) | 2 (0.6%) |
| Material Services | 152 | 3 (2.0%) | 17 (11.2%) | 7 (4.6%) | 15 (9.9%) | 4 (2.6%) | 101 (66.4%) | 5 (3.3%) | 0 |
| Office and Clerical | 741 | 5 (0.7%) | 34 (4.6%) | 31 (4.2%) | 113 (15.2%) | 8 (1.1%) | 521 (70.3%) | 27 (3.6%) | 2 (0.3%) |
| Patient and Family Services | 220 | 2 (0.9%) | 12 (5.5%) | 12 (5.5%) | 27 (12.3%) | 1 (0.5%) | 161 (73.2%) | 5 (2.3%) | 0 |
Abbreviations: RN, registered nurse.
Pre- and Postoutreach Vaccination Completion by Ethnicity
| Characteristics | All Employees | American Indian/Alaskan Native | Asian/Pacific Islander | Black | Hispanic | Hawaiian/Other Pacific Islander | White | Two or more races (not Hispanic) | Not indicated | |
|---|---|---|---|---|---|---|---|---|---|---|
|
| N | 13942 | 87 (0.6%) | 1204 (8.6%) | 566 (4.1%) | 1175 (8.4%) | 121 (0.9%) | 10351 (74.2%) | 399 (2.9%) | 39 (0.3%) |
| Complete Vaccination | ||||||||||
| Overall | 11670 (83.7%) | 67 (77%) | 1078 (89.5%) | 408 (72.1%) | 933 (79.4%) | 103 (85.1%) | 8740 (84.4%) | 314 (78.7%) | 27 (69.2%) | |
| Age, Years | ||||||||||
| <40 | 4848 (80%) | 22 (66.7%) | 480 (87.8%) | 150 (63.6%) | 551 (77%) | 45 (79%) | 3381 (81%) | 200 (76.3%) | 19 (70.4%) | |
| 40-64 | 6325 (86%) | 43 (82.7%) | 558 (91%) | 232 (76.3%) | 369 (83.7%) | 54 (90%) | 4952 (86.6%) | 109 (82.6%) | 8 (66.7%) | |
| 65 and above | 497 (90%) | 2 (100%) | 40(91%) | 26 (100%) | 13 (72.2%) | 4 (100%) | 407 (89.5%) | 5 (100%) | 0 | |
| Gender | ||||||||||
| Female | 8893 (83%) | 53 (79.1%) | 774 (89.8%) | 277 (68.2%) | 684 (77.7%) | 75 (87.2%) | 6761 (83.8%) | 245 (78.5%) | 24 (77.4%) | |
| Male | 2774 (86%) | 14 (70%) | 303 (88.9%) | 131 (81.9%) | 249 (84.4%) | 28 (80%) | 1977 (86.8%) | 69 (79.3%) | 3 (42.9%) | |
| Not Indicated | 3 (60%) | 0 | 1 (100%) | 0 | 0 | 0 | 2 (66.7%) | 0 | 0 | |
| Incomplete Vaccination | ||||||||||
| Overall | 2272 (16.3%) | 20 (23%) | 126 (10.5%) | 158 (27.9%) | 242 (20.6%) | 18 (14.9%) | 1611 (15.6%) | 85 (21.3%) | 12 (30.8%) | |
| Age | ||||||||||
| <40 | 1206 (20%) | 11 (33.3%) | 67 (12.2%) | 86 (36.4%) | 165 (23%) | 12 (21.1%) | 795 (19%) | 62 (23.7%) | 8 (29.6%) | |
| 40-64 | 1009 (14%) | 9 (17.3%) | 55 (9%) | 72 (23.7%) | 72 (16.3%) | 6 (10%) | 768 (13.4%) | 23 (17.4%) | 4 (33.3%) | |
| 65 and above | 57 (10%) | 0 | 4 (9.1%) | 0 | 5 (27.8%) | 0 | 48 (0.9%) | 0 | 0 | |
| Gender | ||||||||||
| Female | 1822 (17%) | 14 (20.9%) | 88 (10.2%) | 129 (31.8%) | 196 (22.3%) | 11 (12.8%) | 1310 (16.2%) | 67 (21.5%) | 7 (22.6%) | |
| Male | 448 (14%) | 6 (30%) | 38 (11.1%) | 29 (18.1%) | 46 (15.6%) | 7 (20%) | 300 (13.2%) | 18 (20.7%) | 4 (57.1%) | |
| Not Indicated | 2 (40%) | 0 | 0 | 0 | 0 | 0 | 1 (33.3%) | 0 | 1 (100%) | |
|
| N | 13969 | 86 (0.6%) | 1220 (8.7%) | 564 (4%) | 1178 (8.4%) | 123 (0.9%) | 10345 (74%) | 405 (2.9%) | 48 (0.3%) |
| Complete Vaccination | ||||||||||
| Overall | 13061 (93.5%) | 78 (90.7%) | 1192 (97.7%) | 511 (90.6%) | 1101 (93.5%) | 119 (96.7%) | 9643 (93.2%) | 375 (92.6%) | 42 (89.4%) | |
| Age, Years | ||||||||||
| <40 | 5579 (92%) | 27 (84.4%) | 536 (97.1%) | 197 (85.7%) | 664 (92.6%) | 56 (95%) | 3820 (91.3%) | 246 (92.5%) | 33 (91.7%) | |
| 40-64 | 6944 (95%) | 49 (94.2%) | 613 (98.4%) | 287 (93.5%) | 421 (95%) | 59 (98.3%) | 5381 (94.5%) | 124 (92.5%) | 10 (83.3%) | |
| 65 and above | 539 (96%) | 2 (100%) | 43 (95.6%) | 27 (100%) | 16 (88.9%) | 4 (100%) | 442 (95.5%) | 5 (100%) | 0 | |
| Gender | ||||||||||
| Female | 9985 (93%) | 63 (91.3%) | 854 (97.6%) | 360 (88.5%) | 824 (92.8%) | 85 (95.6%) | 7472 (92.7%) | 292 (92.7%) | 34 (94.4%) | |
| Male | 3068 (95%) | 15 (88.2%) | 337 (98%) | 151 (96.2%) | 277 (95.5%) | 34 (97.1%) | 2165 (95%) | 83 (92.2%) | 6 (75%) | |
| Not Indicated | 9 (90%) | 0 | 1 (100%) | 0 | 0 | 0 | 6 (100%) | 0 | 2 (66.7%) | |
| Unvaccinated | ||||||||||
| Overall | 907 (6.5%) | 8 (9.3%) | 28 (2.3%) | 53 (9.4%) | 77 (6.5%) | 4 (3.3%) | 702 (6.8%) | 30 (7.5%) | 5 (10.6%) | |
| Age, Years | ||||||||||
| <40 | 498 (8%) | 5 (15.6%) | 16 (2.9%) | 33 (14.3%) | 53 (7.4%) | 3 (5.1%) | 365 (8.7%) | 20 (7.5%) | 3 (8.3%) | |
| 40-64 | 384 (5%) | 3 (5.8%) | 10 (1.6%) | 20 (6.5%) | 22 (5%) | 1 (1.7%) | 316 (5.5%) | 10 (7.5%) | 2 (16.7%) | |
| 65 and above | 25 (4%) | 0 | 2 (4.4%) | 0 | 2 (11.1%) | 0 | 21 (4.5%) | 0 | 0 | |
| Gender | ||||||||||
| Female | 755 (7%) | 6 (8.7%) | 21 (2.4%) | 47 (11.5%) | 64 (7.2%) | 3 (3.4%) | 589 (7.3%) | 23 (7.3%) | 2 (5.6%) | |
| Male | 151 (5%) | 2 (11.8%) | 7 (2%) | 6 (3.8%) | 13 (4.5%) | 1 (2.9%) | 113 (5.0%) | 7 (7.8%) | 2 (25%) | |
| Not Indicated | 1 (10%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 (33.3%) | |
| Incomplete Vaccination | ||||||||||
| Overall | 151 | 2 (2.3%) | 9 (0.7%) | 16 (2.8%) | 20 (1.7%) | 2 (1.6%) | 94 (0.9%) | 6 (1.5%) | 2 (4.2%) | |
| Difference in Complete Vaccination (Post-Intervention from Pre-Intervention) | ||||||||||
| Overall | 1391 (9.8%) | 11 (13.7%) | 114 (8.2%) | 103 (18.5%) | 168 (14.1%) | 16 (11.6%) | 903 (8.8%) | 61 (13.9%) | 15 (18.3%) | |
Abbreviations: mRNA, messenger ribunucleic acid.
Incomplete Vaccination: 1 dose mRNA vaccine received.
Top 10 Pre- and Postoutreach Vaccination Completion Increases by Job Classes
| September 2, 2021 | October 4, 2021 | ||||
|---|---|---|---|---|---|
| Job Class | Vaccinated | Unvaccinated | Vaccinated | Unvaccinated | Increase |
| Safety/Security | 86 (66.2%) | 44 (33.8%) | 119 (93.0%) | 9 (7.0%) | 26.8% |
| Housekeeping Services | 372 (69.8%) | 161 (30.2%) | 471 (89.4%) | 56 (10.6%) | 19.6% |
| Patient Care, non-RN | 957 (72.8%) | 357 (27.2%) | 1171 (89.3%) | 141 (10.7%) | 16.4% |
| Food and Nutrition Services | 341 (79.7%) | 87 (20.3%) | 401 (93.7%) | 27 (6.3%) | 14.0% |
| Facilities Maintenance | 125 (79.6%) | 32 (20.4%) | 147 (93.6%) | 10 (6.4%) | 14.0% |
| Clinics | 254 (78.6%) | 69 (21.4%) | 295 (91.9%) | 26 (8.1%) | 13.3% |
| Health Information Management | 255 (72.6%) | 96 (27.4%) | 302 (85.8%) | 50 (14.2%) | 13.1% |
| Material Services | 124 (81.6%) | 28 (18.4%) | 143 (94.7%) | 8 (5.3%) | 13.1% |
| Office and Clerical | 589 (79.5%) | 152 (20.5%) | 692 (92.6%) | 55 (7.4%) | 13.2% |
| Patient and Family Services | 180 (81.8%) | 40 (18.2%) | 209 (92.9%) | 16 (7.1%) | 11.1% |
Abbreviations: RN, registered nurse.
Unvaccinated: having received no vaccine administration, or 1 dose of mRNA vaccine.
Frequent Themes From Town Halls and Hotlines
| Town Halls | Clinician Hotline | Triage Hotline |
|---|---|---|
| Natural immunity | Anticipated side effects | Help on where to get a vaccine and/or schedule a vaccine appointment |
| Breakthrough infections | Negative 1st-dose experience | Timing of getting the vaccine and adhering to organization’s vaccine requirement (ie, unpaid administrative leave and employment termination deadlines) |
| Vaccine development and approval was too fast | Pre-existing health condition | Medical or religious exceptions (out of scope, would redirect to Human Resources or Employee Health) |
| Effects of mRNA on the body | Allergies to other meds | Help on where to get a vaccine and/or schedule a vaccine appointment |
| Vaccine safety with fertility, pregnancy, breastfeeding | Vaccine safety with pregnancy and breastfeeding | COVID-19 exposure (out of scope, redirect to Employee Health) |
| Long-term side effects (ie, 10 years) | Received 1st dose several months ago and/or want to switch brands | Negative side effects from recently received vaccine (out of scope, redirect to Employee Health) |
| Fetal cell use in vaccine development | Fetal cell use in vaccine development | Booster availability (Out of Scope) |
| Difference between FDA-approved and EUA-approved Pfizer-BioNtech vaccine | Difference between FDA-approved and EUA-approved Pfizer-BioNtech vaccine | |
| VAERS data | When to get the vaccine if recently sick or exposed to COVID-19 | |
| When to get the vaccine if recently sick or exposed to COVID-19 | Blood clot risks |
Abbreviations: COVID-19, coronavirus disease 2019; EUA, Emergency Use Authorization; FDA, US Food and Drug Administration; meds, medications; mRNA, messenger ribonucleic acid; VAERS, Vaccine Adverse Event Reporting System.